Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yiqi Zhixue Granule is a traditional Chinese medicine (TCM) formulation presented in granular form. It is composed of a blend of several herbal ingredients, including Dangshen (Codonsis Radix), Huangqi (Astragali Radix), Baizhu (Atractylodis Macrocephalae Rhizoma), Fuling (Poria), Baiji (Bletillae Rhizoma), Gonglaoye (Mahoniae Folium), Dihuang (Rehmanniae Radix), and Fangfeng (Saposhnikoviae Radix). This combination is traditionally used to replenish Qi, stop bleeding, consolidate the exterior, and strengthen the spleen. It is indicated for various bleeding symptoms, such as hemoptysis and hematemesis, particularly those arising from Qi deficiency and blood stasis. Long-term use is also suggested for preventing common colds. Clinical applications include functional uterine bleeding and digestive tract bleeding.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yiqi Zhixue Granule.